Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor
Open Access
- 16 June 2021
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-16
Abstract
Background: Circulating tumor cells (CTCs) are the dominant factor leading to tumor metastasis. This study aims to investigate the effect of disparate sources of CTCs on the treatment and prognosis of patients with advanced tumors by analyzing the number and gene mutations change of CTCs in arterial and venous blood in patients with advanced tumors. Results: A CTCs sorting system was constructed based on Vimentin-immunolipid magnetic balls (Vi-IMB) and EpCAM immunolipid magnetic balls (Ep-IMB). Results showed that the prepared Ep-IMB and Vi-IMB had lower cytotoxicity, better specificity and sensitivity. The number of arterial CTCs was higher than that of venous CTCs, with a statistically significant difference (P < 0.05). Moreover, the prognosis of the low positive group of total CTCs in arterial blood and venous blood was higher than that of the high positive group, with a statistical significance (P < 0.05). The genetic testing results showed that the targeted drug gene mutations in tissues, arterial CTCs and venous CTCs showed a complementary trend, indicating that there was heterogeneity among different tumor samples. Conclusions: CTCs in blood can be efficiently captured by the CTCs sorting system based on Vi-LMB/Ep-LMB, and CTCs detection in arterial blood can be utilized to more accurately evaluate the prognosis and predict postoperative progress. It is further confirmed that tumor samples from disparate sources are heterogeneous, providing a reference basis for gene mutation detection before clinical targeted drug treatment, and the detection of CTCs in arterial blood has more potential clinical application value. Trial registration: The Ethics Committee of Putuo Hospital, PTEC-A-2019-18-1. Registered 24 September 2019. GraphicKeywords
Funding Information
- Putuo district clinical Chinese medicine fund (PTZYLCZDZK-2017001/ptzyzk2101)
- The Clinical Special Project fund of Shanghai Municipal Health Commission (20204Y0153)
This publication has 36 references indexed in Scilit:
- FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal CancerPLOS ONE, 2013
- Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem CellsPathobiology, 2012
- IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere culturesInternational Journal of Oncology, 2011
- Aldehyde Dehydrogenase–Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to CancerCancer Research, 2009
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cellsOncogene, 2009
- EMT: When epithelial cells decide to become mesenchymal-like cellsJournal of Clinical Investigation, 2009
- Detection, clinical relevance and specific biological properties of disseminating cancer cells in breast cancer patients.Cancer Research, 2009
- Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast CancerCancer Research, 2008
- Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local RelapseClinical Cancer Research, 2008
- Metastasis: recent discoveries and novel treatment strategiesThe Lancet, 2007